Schwartz JC - Search Results

1

General construction pattern of histamine H3-receptor antagonists: change of a paradigm.

Stark H, Ligneau X, Arrang JM, Schwartz JC, Schunack W. Stark H, et al. Among authors: schwartz jc. Bioorg Med Chem Lett. 1998 Aug 4;8(15):2011-6. doi: 10.1016/s0960-894x(98)00342-4. Bioorg Med Chem Lett. 1998. PMID: 9873477

2

Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity.

Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Apelt J, et al. Among authors: schwartz jc. J Med Chem. 2002 Feb 28;45(5):1128-41. doi: 10.1021/jm0110845. J Med Chem. 2002. PMID: 11855993

3

Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonists.

Grassmann S, Sadek B, Ligneau X, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Stark H, Schunack W. Grassmann S, et al. Among authors: schwartz jc. Eur J Pharm Sci. 2002 May;15(4):367-78. doi: 10.1016/s0928-0987(02)00024-6. Eur J Pharm Sci. 2002. PMID: 11988398

4

Piperidino-hydrocarbon compounds as novel non-imidazole histamine H(3)-receptor antagonists.

Meier G, Ligneau X, Pertz HH, Ganellin CR, Schwartz JC, Schunack W, Stark H. Meier G, et al. Among authors: schwartz jc. Bioorg Med Chem. 2002 Aug;10(8):2535-42. doi: 10.1016/s0968-0896(02)00115-3. Bioorg Med Chem. 2002. PMID: 12057642

5

Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.

Sasse A, Ligneau X, Rouleau A, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Sasse A, et al. Among authors: schwartz jc. J Med Chem. 2002 Aug 29;45(18):4000-10. doi: 10.1021/jm020910m. J Med Chem. 2002. PMID: 12190321

6

Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.

Mikó T, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Mikó T, et al. Among authors: schwartz jc. J Med Chem. 2003 Apr 10;46(8):1523-30. doi: 10.1021/jm021084k. J Med Chem. 2003. PMID: 12672253

7

Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.

Mikó T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Mikó T, et al. Among authors: schwartz jc. Bioorg Med Chem. 2004 May 15;12(10):2727-36. doi: 10.1016/j.bmc.2004.03.009. Bioorg Med Chem. 2004. PMID: 15110854

8

4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.

Meier G, Krause M, Hüls A, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Meier G, et al. Among authors: schwartz jc. J Med Chem. 2004 May 6;47(10):2678-87. doi: 10.1021/jm031065q. J Med Chem. 2004. PMID: 15115409

9

Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.

Pelloux-Léon N, Fkyerat A, Piripitsi A, Tertiuk W, Schunack W, Stark H, Garbarg M, Ligneau X, Arrang JM, Schwartz JC, Ganellin CR. Pelloux-Léon N, et al. Among authors: schwartz jc. J Med Chem. 2004 Jun 3;47(12):3264-74. doi: 10.1021/jm031141p. J Med Chem. 2004. PMID: 15163206

10

Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivatives.

Grassmann S, Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Grassmann S, et al. Among authors: schwartz jc. Arch Pharm (Weinheim). 2004 Oct;337(10):533-45. doi: 10.1002/ardp.200400897. Arch Pharm (Weinheim). 2004. PMID: 15476285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters